descriptive
Analysis v1
Strong Support
Among people taking testosterone as part of gender-affirming care, most don’t develop dangerously high red blood cell counts — only a small number go above normal levels, so it’s not a common problem.
35
0
Evidence from Studies
Supporting (1)
35
Community contributions welcome
35
Erythrocytosis Is Rare With Exogenous Testosterone in Gender-Affirming Hormone Therapy.
Cross-Sectional Study
Human
2024 Apr 19This study looked at thousands of people taking testosterone for gender affirmation and found that only a small number had unusually high red blood cell levels — so high levels are rare, just like the claim says.
Contradicting (0)
0
Community contributions welcome
No contradicting evidence found
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.